JFG
ONC

Jefferies Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Jefferies Financial Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-19,800
Closed -$4.45M – 1918
2024
Q3 		$4.45M Buy
+19,800
New +$3.56M 0.03% 345

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jefferies Financial Group's ONC Position: Q2 2026 in Review

Jefferies Financial Group increased its BeOne Medicines Ltd (ONC) stake by 3.2% in Q2 2026, buying an estimated $58.9K and bringing the position to 6,400 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #726.

Jefferies Financial Group first reported a position in ONC in Q3 2023 and has held it in 9 quarters since. The position peaked at $8.3M in Q4 2023. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Jefferies Financial Group held 6,400 shares of BeOne Medicines Ltd worth $1.82M as of Q2 2026.
  • Jefferies Financial Group bought 200 BeOne Medicines Ltd shares in Q2 2026, an estimated $58.9K.
  • BeOne Medicines Ltd made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #726 holding.
  • Jefferies Financial Group first reported a position in BeOne Medicines Ltd in Q3 2023 and has held it in 9 quarters since.
  • Jefferies Financial Group's BeOne Medicines Ltd position peaked at $8.3M in Q4 2023.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.